Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016
Published Aug 17, 2016
46 pages — Published Aug 17, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016, provides an overview of the Jeil Pharmaceutical Co., Ltd.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Jeil Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Jeil Pharmaceutical Co., Ltd.
- The report provides overview of Jeil Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Jeil Pharmaceutical Co., Ltd.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Jeil Pharmaceutical Co., Ltd.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Jeil Pharmaceutical Co., Ltd.s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Jeil Pharmaceutical Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Jeil Pharmaceutical Co., Ltd.s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potenti

  
Source:
Document ID
GMDHC08119CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Jeil Pharmaceutical Co., Ltd. Snapshot61
  Jeil Pharmaceutical Co., Ltd. Overview61
  Key Information61
  Key Facts61
Jeil Pharmaceutical Co., Ltd. Research and Development Overview73
  Key Therapeutic Areas73
Jeil Pharmaceutical Co., Ltd. Pipeline Review103
  Pipeline Products by Stage of Development101
  Pipeline Products Monotherapy111
  Pipeline Products Combination Treatment Modalities121
Jeil Pharmaceutical Co., Ltd. Pipeline Products Glance134
  Jeil Pharmaceutical Co., Ltd. Late Stage Pipeline Products131
    Phase III Products/Combination Treatment Modalities131
  Jeil Pharmaceutical Co., Ltd. Clinical Stage Pipeline Products141
    Phase I Products/Combination Treatment Modalities141
  Jeil Pharmaceutical Co., Ltd. Early Stage Pipeline Products151
    Preclinical Products/Combination Treatment Modalities151
    Discovery Products/Combination Treatment Modalities161
Jeil Pharmaceutical Co., Ltd. Drug Profiles1718
  (solifenacin succinate + tamsulosin hydrochloride)171
    Product Description171
    Mechanism of Action171
    R&D Progress171
  JLP-1401181
    Product Description181
    Mechanism of Action181
    R&D Progress181
  metformin hydrochloride + rosuvastatin calcium191
    Product Description191
    Mechanism of Action191
    R&D Progress191
  JJP-1305201
    Product Description201
    Mechanism of Action201
    R&D Progress201
  JPI-289211
    Product Description211
    Mechanism of Action211
    R&D Progress211
  JGK-263221
    Product Description221
    Mechanism of Action221
    R&D Progress221
  JLP-1601231
    Product Description231
    Mechanism of Action231
    R&D Progress231
  JLP-1604241
    Product Description241
    Mechanism of Action241
    R&D Progress241
  JP-1366251
    Product Description251
    Mechanism of Action251
    R&D Progress251
  JP-2266261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  JPI-547271
    Product Description271
    Mechanism of Action271
    R&D Progress271
  Small Molecule for Degenerative Arthritis281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  Small Molecule for Hypertriglyceridaemia291
    Product Description291
    Mechanism of Action291
    R&D Progress291
  Stem Cell Therapy for Parkinson's Disease and Age-Related Macular Degeneration301
    Product Description301
    Mechanism of Action301
    R&D Progress301
  JLP-1602311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  JLP-1603321
    Product Description321
    Mechanism of Action321
    R&D Progress321
  Small Molecule to Inhibit FLT3 for Acute Myeloid Leukemia331
    Product Description331
    Mechanism of Action331
    R&D Progress331
  Small Molecules for Neuropathic Pain341
    Product Description341
    Mechanism of Action341
    R&D Progress341
Jeil Pharmaceutical Co., Ltd. Pipeline Analysis355
  Jeil Pharmaceutical Co., Ltd. Pipeline Products by Target352
  Jeil Pharmaceutical Co., Ltd. Pipeline Products by Route of Administration371
  Jeil Pharmaceutical Co., Ltd. Pipeline Products by Molecule Type381
  Jeil Pharmaceutical Co., Ltd. Pipeline Products by Mechanism of Action391
Jeil Pharmaceutical Co., Ltd. Recent Pipeline Updates401
Jeil Pharmaceutical Co., Ltd. Dormant Projects411
Jeil Pharmaceutical Co., Ltd. Company Statement421
Jeil Pharmaceutical Co., Ltd. Locations And Subsidiaries432
  Head Office431
  Other Locations &Subsidiaries432
Appendix452
  Methodology451
  Coverage451
  Secondary Research451
  Primary Research451
  Expert Panel Validation451
  Contact Us451
  Disclaimer461

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016" Aug 17, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Jeil-Pharmaceutical-Co-Ltd-Product-Pipeline-Review-2016-2088-16405>
  
APA:
Global Markets Direct - Market Research. (2016). Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016 Aug 17, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Jeil-Pharmaceutical-Co-Ltd-Product-Pipeline-Review-2016-2088-16405>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.